Significance of serum free prostate specific antigen in the screening of prostate cancer.

[1]  W. Catalona,et al.  Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. , 1995, JAMA.

[2]  J. Oesterling,et al.  Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. , 1995, The Journal of urology.

[3]  T. P. Ball,et al.  The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels. , 1995, The Journal of urology.

[4]  H. Yamanaka,et al.  Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer. , 1995, The Journal of urology.

[5]  J. Oesterling,et al.  The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older. , 1995, The Journal of urology.

[6]  F. Mostofi,et al.  Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project. , 1994, The Journal of urology.

[7]  W. Catalona,et al.  Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. , 1993, JAMA.

[8]  C G Chute,et al.  Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. , 1993, JAMA.

[9]  O. Nilsson,et al.  Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. , 1993, The Journal of urology.

[10]  W. Catalona.  Re: Serum Prostate Specific Antigen as Pre-Screening Test for Prostate Cancer, by F. Labrie, A. Dupont, R. Suburu, L. Cusan, M. Tremblay, J.-L. Gomez and J. Emond, J. Urol., 147: 846–852, 1992 , 1993 .

[11]  U. Norming,et al.  Diagnostic methods in the detection of prostate cancer: a study of a randomly selected population of 2,400 men. , 1992, The Journal of urology.

[12]  H. Lilja,et al.  Prostate specific antigen predominantly forms a complex with alpha1‐antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum , 1992, Cancer.

[13]  E. Metter,et al.  Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. , 1992, JAMA.

[14]  M. Benson,et al.  The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. , 1992, The Journal of urology.

[15]  J. Goméz,et al.  Serum prostate specific antigen as pre-screening test for prostate cancer. , 1992, The Journal of urology.

[16]  J. Oesterling,et al.  Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. , 1991, The Journal of urology.

[17]  W. Catalona,et al.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.

[18]  H. Fuse,et al.  [Clinical studies on endocrine therapy of prostatic carcinoma (2): Prognosis of patients with prostatic carcinoma given endocrine therapy, and analyses of causes of death and side effects of endocrine therapy]. , 1990, Hinyokika kiyo. Acta urologica Japonica.

[19]  T. Stamey,et al.  Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate , 1987 .

[20]  P. Wingo,et al.  Cancer statistics, 1995 , 1995, CA: a cancer journal for clinicians.

[21]  J. Estève,et al.  Cancer in the European Community and its member states. , 1990, European journal of cancer.